Recently, domestic surgicalrobotEnterprise elitethe medicalThe self-developed porous laparoscopic surgery robot MP1000 has been approved by the State Drug Administration for marketing. The registration application for this product was completed in January this year. It can be widely used in urology, gynecology, general surgery and thoracic surgery, and has completed registration clinical trial enrollment in urology, gynecology, general surgery and thoracic surgery.
It is inseparable from the safety and advancement of the product to be approved for marketing. It is understood that MP1000 adopts technical routes such as master-slave control, intuitive teleoperation and multi-arm structure, and is equipped with a high-definition 3D endoscope. It can provide doctors with good hand-eye coordination, flexibility and precision beyond human hands in a narrow space, comfortable operating experience and excellent 3D visual effects. The operation efficiency is greatly improved, and the clinical test performance is outstanding.
In addition to the outstanding performance of this robot, the company’s single-hole laparoscopic surgery robot SP1000 gynecology clinical has been completed, led by Academician Lang Jinghe, and jointly carried out with 301 Hospital and other hospitals. The first domestic single-port robot-assisted total hysterectomy, the first domestic single-port robot-assisted gynecological surgery, and the first domestic single-port robot-assisted radical cervical cancer surgery have been completed.
Founded in 2017, Jingfeng Medical is committed to the development and popularization of intelligent surgical robot platforms. After completing the cross-round financing in December 2021, its valuation exceeded US$1.5 billion (equivalent to approximately RMB 10.6 billion). It has been established for 5 years, and the main design and development of multi-hole surgical robot MP1000 and single-hole laparoscopic surgery robot SP1000 only took 4 years. Currently, the company has more than 460 granted patents and patent applications worldwide. Has independently mastered a number of core technologies involved in surgical Robots, including structural design, system control, motion algorithms, and artificial intelligence algorithms.
At present, Jingfeng Medical has four major product pipelines centered on robotics, including the most widely used multi-hole laparoscopic surgery robot system, the single-hole laparoscopic surgery robot system representing the development direction of surgery, and the natural cavity laparoscopic surgery robot system. surgical robots and traditional minimally invasive surgical instruments.
The Links: 3HNA015218-001 3HAC037310-001 IGBT